ID   MDA-T85
AC   CVCL_QW84
DR   ATCC; CRL-3354
DR   cancercelllines; CVCL_QW84
DR   Cosmic; 2612754
DR   Wikidata; Q54904663
RX   PubMed=25427145;
RX   PubMed=30737244;
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=25427145; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000012601; Zygosity=Heterozygous (PubMed=25427145; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=25427145; PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-3354; PubMed=25427145; PubMed=30737244
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 9,10
ST   D16S539: 10
ST   D5S818: 9,12
ST   D7S820: 11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 18
//
RX   PubMed=25427145; DOI=10.1210/jc.2014-2624; PMCID=PMC4318904;
RA   Henderson Y.C., Ahn S.-H., Ryu J., Chen Y.-Y., Williams M.D.,
RA   El-Naggar A.K., Gagea M., Schweppe R.E., Haugen B.R., Lai S.Y.,
RA   Clayman G.L.;
RT   "Development and characterization of six new human papillary thyroid
RT   carcinoma cell lines.";
RL   J. Clin. Endocrinol. Metab. 100:E243-E252(2015).
//
RX   PubMed=30737244; DOI=10.1158/1078-0432.CCR-18-2953; PMCID=PMC6522280;
RA   Landa I., Pozdeyev N., Korch C.T., Marlow L.A., Smallridge R.C.,
RA   Copland J.A. 3rd, Henderson Y.C., Lai S.Y., Clayman G.L., Onoda N.,
RA   Tan A.-C., Garcia-Rendueles M.E.R., Knauf J.A., Haugen B.R.,
RA   Fagin J.A., Schweppe R.E.;
RT   "Comprehensive genetic characterization of human thyroid cancer cell
RT   lines: a validated panel for preclinical studies.";
RL   Clin. Cancer Res. 25:3141-3151(2019).
//